search
Back to results

Patient Satisfaction With Virtual Post Operative Visits: Hip Arthroscopy

Primary Purpose

Femoroacetabular Impingement

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
virtual doctor visit
Standard care doctor's visit
Sponsored by
NYU Langone Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Femoroacetabular Impingement

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Participants undergoing arthroscopic hip surgery

Exclusion Criteria:

  • Age < 18 years old or Age > 70 years old

Sites / Locations

  • NYU Langone Health

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Telemedicine Post Op

In-Office Post Op

Arm Description

Patients with an even-ending medical record number (0,2,4,6,8) will be randomized to virtual visit/telemedicine. This will be done by using Epic and MyChart-integrated telemedicine functionality for video visits with the Principal Investigator's patients. This is considered standard of care.

Patients with an odd-ending medical record number (1,3,5,7,9) will be randomized to the office visit.

Outcomes

Primary Outcome Measures

Change in patient satisfaction
Participant satisfaction will be measured by a electronic survey . At the conclusion of the in-person or virtual visit, participants will be provided instructions how to access the survey questions through the QR code if in-person and through a secure link if at home via telemedicine through EPIC.

Secondary Outcome Measures

Full Information

First Posted
March 6, 2020
Last Updated
January 14, 2022
Sponsor
NYU Langone Health
search

1. Study Identification

Unique Protocol Identification Number
NCT04302077
Brief Title
Patient Satisfaction With Virtual Post Operative Visits: Hip Arthroscopy
Official Title
Patient Satisfaction With Virtual Post Operative Visits: Hip Arthroscopy
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
March 15, 2020 (Actual)
Primary Completion Date
April 1, 2021 (Actual)
Study Completion Date
May 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NYU Langone Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a prospective, randomized study designed to evaluate the effects of different initial postoperative follow-up modalities. Given the nature of the study, it is not possible for either the surgeons or the subjects to be blinded. Patients will be assigned to either group based on the last digit of their medical record number (MRN). Patients with an even-ending medical record number will be randomized to virtual visit/telemedicine, while patients with an odd-ending medical record number will be randomized to the office visit.
Detailed Description
This study aims to evaluate the differences between two forms of postoperative follow-up with respect to patient satisfaction. The primary outcome will be patient satisfaction with their surgeon and with their overall experience. Following their second postoperative visit, the subjects will complete one electronic survey. The survey is designed to assess subject's overall satisfaction and satisfaction with their surgery. This survey is standardized and will be used by both groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Femoroacetabular Impingement

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
75 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Telemedicine Post Op
Arm Type
Active Comparator
Arm Description
Patients with an even-ending medical record number (0,2,4,6,8) will be randomized to virtual visit/telemedicine. This will be done by using Epic and MyChart-integrated telemedicine functionality for video visits with the Principal Investigator's patients. This is considered standard of care.
Arm Title
In-Office Post Op
Arm Type
Active Comparator
Arm Description
Patients with an odd-ending medical record number (1,3,5,7,9) will be randomized to the office visit.
Intervention Type
Other
Intervention Name(s)
virtual doctor visit
Intervention Description
interactive live-video feed at home through EPIC
Intervention Type
Other
Intervention Name(s)
Standard care doctor's visit
Intervention Description
In person visit as per standard of care
Primary Outcome Measure Information:
Title
Change in patient satisfaction
Description
Participant satisfaction will be measured by a electronic survey . At the conclusion of the in-person or virtual visit, participants will be provided instructions how to access the survey questions through the QR code if in-person and through a secure link if at home via telemedicine through EPIC.
Time Frame
3 month follow up visit

10. Eligibility

Sex
All
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Participants undergoing arthroscopic hip surgery Exclusion Criteria: Age < 18 years old or Age > 70 years old
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Guillem Gonzalez-Lomas
Organizational Affiliation
NYU Langone
Official's Role
Principal Investigator
Facility Information:
Facility Name
NYU Langone Health
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices)
IPD Sharing Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
IPD Sharing Access Criteria
The investigator who proposed to use the data. Upon reasonable request. Requests should be directed to jordan.fried@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Learn more about this trial

Patient Satisfaction With Virtual Post Operative Visits: Hip Arthroscopy

We'll reach out to this number within 24 hrs